McKesson Europe (CAKFY) Stock Price, News & Analysis

Company Overview

McKesson Europe is a leading provider of pharmaceutical distribution and healthcare services across Europe, offering a wide range of products and logistical solutions to pharmacies, hospitals and clinics. Through its extensive wholesale network, the company delivers prescription medicines, over-the-counter drugs and medical consumables, while leveraging advanced supply-chain technologies to ensure timely and cost-effective delivery. In addition to core distribution activities, McKesson Europe operates a network of retail pharmacies under various banners, providing patient counseling, point-of-care testing and vaccination services.

Rooted in its origins as Celesio AG—founded in 1835 in Germany and later listed on the Frankfurt Stock Exchange—the business joined forces with McKesson Corporation in 2014. Today, McKesson Europe is headquartered in Stuttgart and maintains operations in key markets including Germany, the United Kingdom, Italy, Spain, France and several Nordic and Eastern European countries. The integration with McKesson’s global platform has enabled greater scale, access to international procurement and investment in digital health initiatives.

Beyond pharmaceuticals, the company has expanded into specialty distribution, offering customized logistics for complex therapies such as biologics and oncology treatments. McKesson Europe also provides healthcare IT solutions, including pharmacy-management software and e-commerce platforms that support both business-to-business transactions and direct-to-consumer services. Strategic consulting and patient-support programs further enhance its service portfolio, helping manufacturers optimize market access and healthcare providers improve patient adherence.

The European operations are guided by a dedicated executive team based in Stuttgart, working in close collaboration with McKesson’s global leadership. This structure ensures alignment with world-class best practices in compliance, quality assurance and technological innovation. Under this governance framework, McKesson Europe continues to invest in digital transformation, sustainability and partnerships that drive improved outcomes for patients and customers across the region.

Key Stats

• Today's Range: $4.10 to $4.10
• 50-Day Range: $4.10 to $4.10
• 52-Week Range: $4.04 to $4.10
• Volume: N/A
• Average Volume: 10,050 shs
• Market Capitalization: N/A
• P/E Ratio: 47.67
• Dividend Yield: 0.91%
• Price Target: N/A
• Consensus Rating: N/A

CAKFY Stock Analysis - Frequently Asked Questions

How have CAKFY shares performed this year?

McKesson Europe's stock was trading at $4.10 on January 1st, 2025. Since then, CAKFY stock has increased by 0.0% and is now trading at $4.10.

How do I buy shares of McKesson Europe?

Shares of CAKFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CAKFY
• CIK: 1446707
• Web: www.celesio.com
• Phone: (971) 150-0100
• Fax: N/A
• Employees: 26,329
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 47.67
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A